Intrauterine Devices Market By Product Type (Hormonal Intrauterine Device and Copper Intrauterine Device), By Material (Plastic, Copper and Hormonal (Levonorgestrel)), By Age Group (15-24 years, 25-34 years, 35-44 years and Above 44 years), By End-user (Hospital, Gynecology Clinics, Community Health Care Centers and Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Market Outlook

The Intrauterine Devices market accounted for USD 6.35 Billion in 2024 and is expected to reach USD 9.62 Billion by 2035, growing at a CAGR of around 3.85% between 2025 and 2035. The intrauterine devices (IUD) market focuses on contraceptive devices that are inserted into the uterus to prevent pregnancy. IUDs are small, T-shaped devices made from flexible plastic, often with added hormones or copper. Hormonal IUDs release progestin, which thickens cervical mucus and inhibits ovulation, while copper IUDs create a hostile environment for sperm. Known for their effectiveness and long-term useoranging from 3 to 10 yearsothese devices are a popular choice for women seeking reliable contraception without the need for daily maintenance. The growing awareness of reproductive health and family planning options has contributed to the rising adoption of IUDs worldwide, making them a significant segment in the contraceptive market.

Increasing Awareness Drives Demand for Reproductive Health and Family Planning Solutions

Increasing awareness of reproductive health and family planning solutions is a key driver for the growth of the intrauterine devices (IUD) market. As educational initiatives and public health campaigns promote understanding of contraceptive options, more women are recognizing the benefits of IUDs, including their long-term effectiveness and convenience. Additionally, the rising focus on women's health issues and reproductive rights has led to a greater demand for safe and effective contraceptive methods. Health professionals are also advocating for IUDs as a viable option, contributing to their growing acceptance. Furthermore, advancements in IUD technology, such as improved comfort and lower side effects, enhance user satisfaction, encouraging more women to opt for this method. The global trend towards family planning and population control further amplifies the demand for IUDs, positioning them as a crucial component of modern contraceptive strategies.

Concerns Over IUD Side Effects and Complications Limit Market Adoption

Concerns over potential side effects and complications associated with intrauterine devices (IUDs) significantly limit their adoption in the market. Many women experience apprehension regarding the insertion procedure, which can cause discomfort or pain, and the possibility of side effects such as heavy menstrual bleeding, cramping, or hormonal imbalances with hormonal IUDs. Additionally, there are fears of complications like uterine perforation, expulsion, or pelvic inflammatory disease, which can deter women from choosing this contraceptive method. Misconceptions and lack of accurate information about IUDs may further contribute to hesitancy among potential users. Moreover, cultural and societal stigma surrounding contraceptive use can hinder acceptance, particularly in conservative regions. These factors combined create a challenging environment for the widespread adoption of IUDs, impacting market growth.

Segment Analysis

The hormonal intrauterine device (IUD) segment is the most prominent in the intrauterine devices market. Hormonal IUDs, such as those containing levonorgestrel, are highly favored due to their dual benefits of long-term contraception and additional health advantages, such as reduced menstrual bleeding and alleviation of menstrual cramps. Their effectiveness in preventing pregnancy for up to 3 to 7 years has made them a popular choice among women seeking reliable birth control with minimal maintenance. The growing awareness of these benefits, along with endorsements from healthcare providers, has contributed to the increasing adoption of hormonal IUDs, solidifying their dominant position in the market.

The 25-34 years age group is the most prominent segment in the intrauterine devices (IUD) market. Women in this age range often seek effective long-term contraceptive solutions as they plan for families or delay childbirth. This demographic is increasingly educated about reproductive health options and tends to prefer IUDs for their convenience, effectiveness, and low maintenance requirements. Additionally, many women in this group are looking for reliable methods that allow for flexibility in family planning without the need for daily contraception. As a result, this age segment significantly drives the demand for IUDs, making it a crucial focus for manufacturers and healthcare providers in the market.

Regional Analysis

The North American intrauterine devices (IUD) market is characterized by a strong healthcare infrastructure and increasing awareness of reproductive health options. In the U.S. and Canada, there is a growing emphasis on family planning and women's health, which has led to a rise in the adoption of IUDs as a preferred contraceptive method. Healthcare providers actively promote IUDs due to their long-term effectiveness and convenience, resulting in higher acceptance rates among women. Additionally, the availability of various IUD options, including hormonal and copper devices, caters to diverse patient preferences. Regulatory support and favorable reimbursement policies further enhance market growth. However, concerns over side effects and complications persist, which healthcare providers are working to address through education and improved patient support. Overall, North America remains a key market for IUDs, driven by increasing demand for reliable contraceptive solutions.

Competitive Landscape

The competitive landscape of the intrauterine devices (IUD) market features several key players, including Bayer AG, CooperSurgical, Inc., and Merck & Co., Inc. These companies are actively engaged in developing innovative IUD products to meet growing demand. Bayer AG, for instance, has recently expanded its range of hormonal IUDs, enhancing options for women seeking effective contraception. CooperSurgical has made strides in promoting its line of IUDs through educational initiatives aimed at both healthcare providers and patients, increasing awareness and adoption. Additionally, Hologic, Inc. and Teleflex Incorporated are focusing on advancements in IUD technology, such as improved designs for easier insertion and enhanced comfort. Recent collaborations and partnerships among these players aim to streamline distribution and improve patient access, further intensifying competition in the IUD market.

Recent Developments:

• In November 2023, Bayer and CrossBay Medical Inc. announced a cooperation and option to license agreement that will allow for the development and production of a single-handed inserter to be integrated with Bayer's leading hormonal IUS portfolio. This technique improved the company's product portfolio and competitiveness in the marketplace.

• In December 2022, CooperSurgical, Inc. announced a cooperation to introduce a new customer engagement solution for CooperSurgical's hormone-free IUD, Paragard, an FDA-approved intrauterine device that can prevent pregnancy for up to 10 years. This introduction allowed the organization to grow its customer base and improve its sales chances.

Table of Contents
1. Methodology & Report Coverage
1.1. Definition & Objective
1.2. Market Evaluation & forecast parameter
1.3. Research Methodology
1.4. Data Validation Sources
1.4.1. Secondary Research
1.4.2. Primary Research
2. Market Overview
3. Intrauterine Devices Market: Market Dynamics
3.1. Executive Summary
3.2. Market Driving Factors
3.2.1. Government Endorsement Boosting Contraceptive Access and Market Potential
3.2.2. Increasing Awareness Drives Demand for Reproductive Health and Family Planning Solutions
3.2.3. Rising Preference for Long-Term Contraceptive Solutions Fuels Market Growth
3.3. Key industry pitfalls & challenges
3.3.1. Misinformation About IUD Safety and Effectiveness Hinders Market Growth
3.3.2. Concerns Over IUD Side Effects and Complications Limit Market Adoption
3.3.3. High Initial Costs of IUDs and Insertion Procedures Restrict Market Access
3.4. Market Opportunities
3.4.1. Innovative IUDs with Hormonal Benefits Present New Market Opportunities
3.4.2. Eco-Conscious IUDs Leveraging Sustainable Materials for Market Growth
3.4.3. Market Opportunity in Tailored Strategies for IUD Adoption Among Post-Partum Women
3.5. Porter's Five Forces Analysis
3.6. PESTLE Analysis
3.7. Regulatory landscape
3.8. Investment Landscape
3.9. ESG Scenario
3.10. Competitive landscape
3.10.1. Company Market Share 
3.10.2. Market Positioning
3.10.3. Strategy framework
3.10.4. Recent Acquisitions & Mergers
4. Intrauterine Devices Market, Product Type Segment Analysis
4.1. Overview Dynamics
4.1.1. Market Revenue Share, By Product Type, 2025 & 2035
4.1.2. Key Market Trends, Growth Factors, & Opportunities
4.2. Hormonal Intrauterine Device
4.2.1. Market Size and Forecast, 2025-2035 (USD Billion)
4.3. Copper Intrauterine Device
4.3.1. Market Size and Forecast, 2025-2035 (USD Billion)
5. Intrauterine Devices Market, Material Segment Analysis
5.1. Overview
5.1.1. Market Revenue Share, By Material, 2025 & 2035
5.1.2. Key Market Trends, Growth Factors, & Opportunities
5.2. Plastic
5.2.1. Market Size and Forecast, 2025-2035 (USD Billion)
5.3. Copper
5.3.1. Market Size and Forecast, 2025-2035 (USD Billion)
5.4. Hormonal (Levonorgestrel)
5.4.1. Market Size and Forecast, 2025-2035 (USD Billion)
6. Intrauterine Devices Market, Age Group Segment Analysis
6.1. Overview
6.1.1. Market Revenue Share, By Age Group, 2025 & 2035
6.1.2. Key Market Trends, Growth Factors, & Opportunities
6.2. 15-24 years
6.2.1. Market Size and Forecast, 2025-2035 (USD Billion)
6.3. 25-34 years
6.3.1. Market Size and Forecast, 2025-2035 (USD Billion)
6.4. 35-44 years
6.4.1. Market Size and Forecast, 2025-2035 (USD Billion)
6.5. Above 44 years
6.5.1. Market Size and Forecast, 2025-2035 (USD Billion)
7. Intrauterine Devices Market, End-user Segment Analysis
7.1. Overview
7.1.1. Market Revenue Share, By End-user, 2025 & 2035
7.1.2. Key Market Trends, Growth Factors, & Opportunities
7.2. Hospital
7.2.1. Market Size and Forecast, 2025-2035 (USD Billion)
7.3. Gynecology Clinics
7.3.1. Market Size and Forecast, 2025-2035 (USD Billion)
7.4. Community Health Care Centers
7.4.1. Market Size and Forecast, 2025-2035 (USD Billion)
7.5. Others
7.5.1. Market Size and Forecast, 2025-2035 (USD Billion)
8. Intrauterine Devices Market, Region Segment Analysis
8.1. Overview 
8.1.1. Global Market Revenue Share, By Region, 2025 & 2035
8.1.2. Global Market Revenue, By Region, 2025-2035(USD Billion)
8.2. North America 
8.2.1. North America Market Revenue, By Country, 2025-2035(USD Billion)
8.2.2. North America Market Revenue, By Product Type, 2025-2035
8.2.3. North America Market Revenue, By Material, 2025-2035
8.2.4. North America Market Revenue, By Age Group, 2025-2035
8.2.5. North America Market Revenue, By End-user, 2025-2035
8.2.6. The U.S.
8.2.6.1. U.S. Market Revenue, By Product Type, 2025-2035
8.2.6.2. U.S. Market Revenue, By Material, 2025-2035
8.2.6.3. U.S. Market Revenue, By Age Group, 2025-2035
8.2.6.4. U.S. Market Revenue, By End-user, 2025-2035
8.2.7. Canada
8.2.7.1. Canada Market Revenue, By Product Type, 2025-2035
8.2.7.2. Canada Market Revenue, By Material, 2025-2035
8.2.7.3. Canada Market Revenue, By Age Group, 2025-2035
8.2.7.4. Canada Market Revenue, By End-user, 2025-2035
8.3. Europe
8.3.1. Europe Market Revenue, By Country, 2025-2035(USD Billion)
8.3.2. Europe Market Revenue, By Product Type, 2025-2035
8.3.3. Europe Market Revenue, By Material, 2025-2035
8.3.4. Europe Market Revenue, By Age Group, 2025-2035
8.3.5. Europe Market Revenue, By End-user, 2025-2035
8.3.6. Germany
8.3.6.1. Germany Market Revenue, By Product Type, 2025-2035
8.3.6.2. Germany Market Revenue, By Material, 2025-2035
8.3.6.3. Germany Market Revenue, By Age Group, 2025-2035
8.3.6.4. Germany Market Revenue, By End-user, 2025-2035
8.3.7. France
8.3.7.1. France Market Revenue, By Product Type, 2025-2035
8.3.7.2. France Market Revenue, By Material, 2025-2035
8.3.7.3. France Market Revenue, By Age Group, 2025-2035
8.3.7.4. France Market Revenue, By End-user, 2025-2035
8.3.8. U.K.
8.3.8.1. U.K. Market Revenue, By Product Type, 2025-2035
8.3.8.2. U.K. Market Revenue, By Material, 2025-2035
8.3.8.3. U.K. Market Revenue, By Age Group, 2025-2035
8.3.8.4. U.K. Market Revenue, By End-user, 2025-2035
8.3.9. Italy
8.3.9.1. Italy Market Revenue, By Product Type, 2025-2035
8.3.9.2. Italy Market Revenue, By Material, 2025-2035
8.3.9.3. Italy Market Revenue, By Age Group, 2025-2035
8.3.9.4. Italy Market Revenue, By End-user, 2025-2035
8.3.10. Spain
8.3.10.1. Spain Market Revenue, By Product Type, 2025-2035
8.3.10.2. Spain Market Revenue, By Material, 2025-2035
8.3.10.3. Spain Market Revenue, By Age Group, 2025-2035
8.3.10.4. Spain Market Revenue, By End-user, 2025-2035
8.3.11. Rest of Europe
8.3.11.1. Rest of Europe Market Revenue, By Product Type, 2025-2035
8.3.11.2. Rest of Europe Market Revenue, By Material, 2025-2035
8.3.11.3. Rest of Europe Market Revenue, By Age Group, 2025-2035
8.3.11.4. Rest of Europe Market Revenue, By End-user, 2025-2035
8.4. Asia Pacific
8.4.1. Asia Pacific Market Revenue, By Country, 2025-2035(USD Billion)
8.4.2. Asia Pacific Market Revenue, By Product Type, 2025-2035
8.4.3. Asia Pacific Market Revenue, By Material, 2025-2035
8.4.4. Asia Pacific Market Revenue, By Age Group, 2025-2035
8.4.5. Asia Pacific Market Revenue, By End-user, 2025-2035
8.4.6. China
8.4.6.1. China Market Revenue, By Product Type, 2025-2035
8.4.6.2. China Market Revenue, By Material, 2025-2035
8.4.6.3. China Market Revenue, By Age Group, 2025-2035
8.4.6.4. China Market Revenue, By End-user, 2025-2035
8.4.7. Japan
8.4.7.1. Japan Market Revenue, By Product Type, 2025-2035
8.4.7.2. Japan Market Revenue, By Material, 2025-2035
8.4.7.3. Japan Market Revenue, By Age Group, 2025-2035
8.4.7.4. Japan Market Revenue, By End-user, 2025-2035
8.4.8. India
8.4.8.1. India Market Revenue, By Product Type, 2025-2035
8.4.8.2. India Market Revenue, By Material, 2025-2035
8.4.8.3. India Market Revenue, By Age Group, 2025-2035
8.4.8.4. India Market Revenue, By End-user, 2025-2035
8.4.9. Australia
8.4.9.1. Australia Market Revenue, By Product Type, 2025-2035
8.4.9.2. Australia Market Revenue, By Material, 2025-2035
8.4.9.3. Australia Market Revenue, By Age Group, 2025-2035
8.4.9.4. Australia Market Revenue, By End-user, 2025-2035
8.4.10. South Korea
8.4.10.1. South Korea Market Revenue, By Product Type, 2025-2035
8.4.10.2. South Korea Market Revenue, By Material, 2025-2035
8.4.10.3. South Korea Market Revenue, By Age Group, 2025-2035
8.4.10.4. South Korea Market Revenue, By End-user, 2025-2035
8.4.11. Singapore
8.4.11.1. Singapore Market Revenue, By Product Type, 2025-2035
8.4.11.2. Singapore Market Revenue, By Material, 2025-2035
8.4.11.3. Singapore Market Revenue, By Age Group, 2025-2035
8.4.11.4. Singapore Market Revenue, By End-user, 2025-2035
8.4.12. Rest of Asia Pacific
8.4.12.1. Rest of Asia Pacific Market Revenue, By Product Type, 2025-2035
8.4.12.2. Rest of Asia Pacific Market Revenue, By Material, 2025-2035
8.4.12.3. Rest of Asia Pacific Market Revenue, By Age Group, 2025-2035
8.4.12.4. Rest of Asia Pacific Market Revenue, By End-user, 2025-2035
8.5. Latin America
8.5.1. Latin America Market Revenue, By Country, 2025-2035(USD Billion)
8.5.2. Latin America Market Revenue, By Product Type, 2025-2035
8.5.3. Latin America Market Revenue, By Material, 2025-2035
8.5.4. Latin America Market Revenue, By Age Group, 2025-2035
8.5.5. Latin America Market Revenue, By End-user, 2025-2035
8.5.6. Brazil
8.5.6.1. Brazil Market Revenue, By Product Type, 2025-2035
8.5.6.2. Brazil Market Revenue, By Material, 2025-2035
8.5.6.3. Brazil Market Revenue, By Age Group, 2025-2035
8.5.6.4. Brazil Market Revenue, By End-user, 2025-2035
8.5.7. Argentina
8.5.7.1. Argentina Market Revenue, By Product Type, 2025-2035
8.5.7.2. Argentina Market Revenue, By Material, 2025-2035
8.5.7.3. Argentina Market Revenue, By Age Group, 2025-2035
8.5.7.4. Argentina Market Revenue, By End-user, 2025-2035
8.5.8. Mexico
8.5.8.1. Mexico Market Revenue, By Product Type, 2025-2035
8.5.8.2. Mexico Market Revenue, By Material, 2025-2035
8.5.8.3. Mexico Market Revenue, By Age Group, 2025-2035
8.5.8.4. Mexico Market Revenue, By End-user, 2025-2035
8.5.9. Rest of Latin America
8.5.9.1. Rest of Latin America Market Revenue, By Product Type, 2025-2035
8.5.9.2. Rest of Latin America Market Revenue, By Material, 2025-2035
8.5.9.3. Rest of Latin America Market Revenue, By Age Group, 2025-2035
8.5.9.4. Rest of Latin America Market Revenue, By End-user, 2025-2035
8.6. MEA
8.6.1. MEA Market Revenue, By Country, 2025-2035(USD Billion)
8.6.2. MEA Market Revenue, By Product Type, 2025-2035
8.6.3. MEA Market Revenue, By Material, 2025-2035
8.6.4. MEA Market Revenue, By Age Group, 2025-2035
8.6.5. MEA Market Revenue, By End-user, 2025-2035
8.6.6. GCC Countries
8.6.6.1. GCC Countries Market Revenue, By Product Type, 2025-2035
8.6.6.2. GCC Countries Market Revenue, By Material, 2025-2035
8.6.6.3. GCC Countries Market Revenue, By Age Group, 2025-2035
8.6.6.4. GCC Countries Market Revenue, By End-user, 2025-2035
8.6.7. South Africa
8.6.7.1. South Africa Market Revenue, By Product Type, 2025-2035
8.6.7.2. South Africa Market Revenue, By Material, 2025-2035
8.6.7.3. South Africa Market Revenue, By Age Group, 2025-2035
8.6.7.4. South Africa Market Revenue, By End-user, 2025-2035
8.6.8. Rest of Middle-East & Africa
8.6.8.1. Rest of Middle-East & Africa Market Revenue, By Product Type, 2025-2035
8.6.8.2. Rest of Middle-East & Africa Market Revenue, By Material, 2025-2035
8.6.8.3.  Rest of Middle-East & Africa Market Revenue, By Age Group, 2025-2035
8.6.8.4. Rest of Middle-East & Africa Market Revenue, By End-user, 2025-2035
9. Company Profile
9.1. Bayer AG
9.1.1. Business Overview
9.1.2. Financial Performance
9.1.3. Product/Service Offerings
9.1.4. Strategies & recent developments
9.1.5. SWOT Analysis
9.2. CooperSurgical, Inc.
9.2.1. Business Overview
9.2.2. Financial Performance
9.2.3. Product/Service Offerings
9.2.4. Strategies & recent developments
9.2.5. SWOT Analysis
9.3. Merck & Co., Inc.
9.3.1. Business Overview
9.3.2. Financial Performance
9.3.3. Product/Service Offerings
9.3.4. Strategies & recent developments
9.3.5. SWOT Analysis
9.4. Teleflex Incorporated
9.4.1. Business Overview
9.4.2. Financial Performance
9.4.3. Product/Service Offerings
9.4.4. Strategies & recent developments
9.4.5. SWOT Analysis
9.5. Hologic, Inc.
9.5.1. Business Overview
9.5.2. Financial Performance
9.5.3. Product/Service Offerings
9.5.4. Strategies & recent developments
9.5.5. SWOT Analysis
9.6. TOLMAR Pharmaceuticals, Inc.
9.6.1. Business Overview
9.6.2. Financial Performance
9.6.3. Product/Service Offerings
9.6.4. Strategies & recent developments
9.6.5. SWOT Analysis
9.7. Nusil Technology LLC
9.7.1. Business Overview
9.7.2. Financial Performance
9.7.3. Product/Service Offerings
9.7.4. Strategies & recent developments
9.7.5. SWOT Analysis
9.8. Medicraft Limited
9.8.1. Business Overview
9.8.2. Financial Performance
9.8.3. Product/Service Offerings
9.8.4. Strategies & recent developments
9.8.5. SWOT Analysis
9.9. Ethypharm
9.9.1. Business Overview
9.9.2. Financial Performance
9.9.3. Product/Service Offerings
9.9.4. Strategies & recent developments
9.9.5. SWOT Analysis
9.10. Ferring Pharmaceuticals
9.10.1. Business Overview
9.10.2. Financial Performance
9.10.3. Product/Service Offerings
9.10.4. Strategies & recent developments
9.10.5. SWOT Analysis
9.11. VivaSight
9.11.1. Business Overview
9.11.2. Financial Performance
9.11.3. Product/Service Offerings
9.11.4. Strategies & recent developments
9.11.5. SWOT Analysis
9.12. HLL Lifecare Limited
9.12.1. Business Overview
9.12.2. Financial Performance
9.12.3. Product/Service Offerings
9.12.4. Strategies & recent developments
9.12.5. SWOT Analysis
9.13. Suhar International
9.13.1. Business Overview
9.13.2. Financial Performance
9.13.3. Product/Service Offerings
9.13.4. Strategies & recent developments
9.13.5. SWOT Analysis
9.14. Screaming Eagle, LLC
9.14.1. Business Overview
9.14.2. Financial Performance
9.14.3. Product/Service Offerings
9.14.4. Strategies & recent developments
9.14.5. SWOT Analysis
9.15. AstraZeneca PLC
9.15.1. Business Overview
9.15.2. Financial Performance
9.15.3. Product/Service Offerings
9.15.4. Strategies & recent developments
9.15.5. SWOT Analysis

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: Metatech Insights

Related Reports

Intrauterine Devices Market By Product Type (Hormonal Intrauterine Device and Copper Intrauterine Device), By Material (Plastic, Copper and Hormonal (Levonorgestrel)), By Age Group (15-24 years, 25-34 years, 35-44 years and Above 44 years), By End-user (Hospital, Gynecology Clinics, Community Health Care Centers and Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Arterial Thrombectomy Devices Market By Device Type (Aspiration Thrombectomy Devices, Mechanical Thrombectomy Devices, Rheolytic Thrombectomy Devices, Ultrasound-Assisted Thrombectomy Devices, Laser-Based Thrombectomy Devices, Others), By Application (Peripheral Arterial Disease (PAD), Coronary Artery Disease (CAD), Ischemic Stroke, Renal Artery Thrombosis, Acute limb Ischemia, Others), By End-user (Hospitals, Specialty Clinics, Ambulatory Surgical Centers (ASCs), Academic and Research Institutions), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Global Operating Room Infection Control Consumable Competitive Landscape Professional Research Report 2024

Global Oral Fluid Drug Test System Competitive Landscape Professional Research Report 2024

Global Orthopaedics Competitive Landscape Professional Research Report 2024

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support